Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitroMatthew H. Raymonda(University of Rochester Medical Center), Isaac S. Harris(University of Rochester Medical Center)bioRxiv (Cold Spring Harbor Laboratory)November 26, 202010.1101/2020.11.25.398859Cited by 19SaveCiteExport RISWatch citationsRelated PapersSynthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer|Molecular Cell|2020|207